Financhill
Back

Genpact Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
39

G
Genpact

Last Price:
$48.92
Seasonality Move:
5.35%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.13
Seasonality Move:
6.73%
Sell
39
Genpact (G) is a Sell

Is Genpact a Buy, Sell or Hold?

  • The current Genpact [G] share price is $49.10. The Score for G is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • G is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

G Stock Price Chart

What is Genpact's stock price today?

  • The Genpact share price today is $49.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and G is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

G Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.28 Buy
Relative Strength Index (14 RSI): 37.31 Sell
Chaikin Money Flow: -552899 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.38 - 54.72) Sell
Bollinger Bands (100): (40.84 - 50.54) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

G Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.45 Sell
20-day SMA: 53.08 Sell
50-day SMA: 48.68 Buy
200-day SMA: 40.55 Buy
8-day EMA: 51.07 Sell
20-day EMA: 51.55 Sell
50-day EMA: 49.48 Sell
200-day EMA: 42.76 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Genpact Earnings Growth & G Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.32 per share, and an increase next year of $0.36 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Genpact Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):